Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 trial evaluating ASP7487 (OSI-906) combined with bortezomib in relapsed multiple myeloma was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial investigating vaccination with peptides from anti-apoptotic proteins in relapsed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients. [Phase 3]
Phase 3 randomized trial comparing G-CSF alone to intermediate-dose Ara-C plus G-CSF mobilization in multiple myeloma; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide [Phase 2]
Phase 2 trial evaluating pomalidomide or lenalidomide with dexamethasone in relapsed or refractory multiple myeloma previously treated with …
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support [Phase 2]
Phase 2 clinical trial update evaluating carfilzomib in multiple myeloma that relapsed after high-dose melphalan with autologous stem cell s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM) [Phase 2]
Phase 2 trial of tabalumab in previously treated multiple myeloma completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating Samarium Sm-153 lexidronam with zoledronic acid or pamidronate for relapsed/refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating progression after PAD induction followed by autologous stem cell transplantation in newly diagnosed multiple myelom…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients [Phase 3]
Phase 3 trial comparing melphalan, prednisone, and thalidomide versus melphalan and prednisone in elderly multiple myeloma patients; complet…
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM) [Phase 2]
A Phase 2 trial evaluating cyclophosphamide in combination with lenalidomide and dexamethasone for relapsed/refractory multiple myeloma with…
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: 1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial of MK-3475 (pembrolizumab) combined with pomalidomide in relapsed/refractory multiple myeloma; study terminated with posted …
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating cannabidiol for efficacy in multiple myeloma, glioblastoma, and various gastrointestinal cancers…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM [Phase 2]
Phase 2 clinical trial evaluating the Chidamide-Lenalidomide-Dexamethasone (CRD) regimen in relapsed/refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma [Phase 2]
Phase 2 multi-center trial evaluating an anti-PD-1 therapy given during lymphopenia after high-dose therapy with autologous stem cell transp…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: CT Antigen TCR-Engineered T Cells for Myeloma [Phase 1, Phase 2]
Phase 1/2 trial updates for CT antigen TCR-engineered T cells in multiple myeloma; the study is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) [Phase 2]
This Phase 2 trial evaluated the efficacy and safety of the RVD regimen with or without panobinostat in transplant-eligible, newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of CB-839 (telaglenastat), a glutaminase inhibitor, in hematological tu…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a combination of bendamustine, weekly bortezomib, lenalidomide and dexamethasone for multiple myeloma …
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating carfilzomib with high-dose melphalan as a preparative regimen for autologous stem cell transplant in multiple mye…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [Phase 1]
Phase 1 clinical trial evaluating donor T-helper 2 (Th2) cell therapy to prevent graft-versus-host disease after bone marrow transplantation…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM [Phase 2]
A Phase II trial evaluating the combination of bendamustine, dexamethasone, and thalidomide for relapsed/refractory multiple myeloma has com…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma [Phase 2]
Phase 2 trial update of a Bruton's tyrosine kinase inhibitor in relapsed/refractory multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma [NA]
A completed clinical trial evaluating touchscreen-based geriatric assessment and frailty screening in adults with multiple myeloma, sponsore…
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) [Phase 3]
Phase 3 trial evaluating stem cell transplant with lenalidomide maintenance for multiple myeloma has completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Efficacy Study of CYT997 in Multiple Myeloma [Phase 2]
A Phase 2 efficacy trial of CYT997 in relapsed and refractory multiple myeloma has been terminated.